Company Analysis Evotec SE
1. Summary
Advantages
- Current debt level 27.85% is below 100% and has decreased over 5 years from 29.27%.
Disadvantages
- Price (8.27 $) is higher than fair price (4.85 $)
- Dividends (0%) are below the sector average (2.17%).
- The stock's return over the last year (-16.03%) is lower than the sector average (-9.33%).
- The company's current efficiency (ROE=-7.49%) is lower than the sector average (ROE=12.15%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Evotec SE | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -12.9% | 1.6% |
| 90 days | 0% | -14.6% | 4.7% |
| 1 year | -16% | -9.3% | 12.2% |
EVOTF vs Sector: Evotec SE has significantly underperformed the "Healthcare" sector by -6.7% over the past year.
EVOTF vs Market: Evotec SE has significantly underperformed the market by -28.25% over the past year.
Stable price: EVOTF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: EVOTF with weekly volatility of -0.3083% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (8.27 $) is higher than the fair price (4.85 $).
Price is higher than fair: The current price (8.27 $) is 41.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (54.34) is higher than that of the sector as a whole (38.28).
P/E vs Market: The company's P/E (54.34) is lower than that of the market as a whole (59.99).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.41) is lower than that of the sector as a whole (3.52).
P/BV vs Market: The company's P/BV (1.41) is lower than that of the market as a whole (3.41).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.02) is lower than that of the sector as a whole (3.74).
P/S vs Market: The company's P/S indicator (2.02) is lower than that of the market as a whole (3.65).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (70.08) is higher than that of the sector as a whole (13.51).
EV/Ebitda vs Market: The company's EV/Ebitda (70.08) is higher than that of the market as a whole (40.09).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -255.43% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-255.43%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.61%).
5.4. ROE
ROE vs Sector: The company's ROE (-7.49%) is lower than that of the sector as a whole (12.15%).
ROE vs Market: The company's ROE (-7.49%) is lower than that of the market as a whole (41.13%).
5.5. ROA
ROA vs Sector: The company's ROA (-3.69%) is lower than that of the sector as a whole (6.06%).
ROA vs Market: The company's ROA (-3.69%) is lower than that of the market as a whole (29.31%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (20.98%) is higher than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (20.98%) is higher than that of the market as a whole (11.01%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.17%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
